267 related articles for article (PubMed ID: 32635790)
1. Impact of Genetically Predicted Red Blood Cell Traits on Venous Thromboembolism: Multivariable Mendelian Randomization Study Using UK Biobank.
Luo S; Au Yeung SL; Zuber V; Burgess S; Schooling CM
J Am Heart Assoc; 2020 Jul; 9(14):e016771. PubMed ID: 32635790
[TBL] [Abstract][Full Text] [Related]
2. A Mendelian randomization study of serum uric acid with the risk of venous thromboembolism.
Ji L; Shu P
Arthritis Res Ther; 2023 Jul; 25(1):122. PubMed ID: 37468959
[TBL] [Abstract][Full Text] [Related]
3. Causal relationship between moderate to vigorous physical activity and venous thromboembolism.
Hu M; Wang X; Yang Y
J Thromb Thrombolysis; 2023 Apr; 55(3):576-583. PubMed ID: 36595107
[TBL] [Abstract][Full Text] [Related]
4. Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation.
Yuan S; Bruzelius M; Larsson SC
J Thromb Thrombolysis; 2022 Jan; 53(1):43-50. PubMed ID: 34043151
[TBL] [Abstract][Full Text] [Related]
5. Leisure sedentary behaviour increases the risk of venous thromboembolism: a Mendelian randomisation study.
Chen L; You G; Yang Z; Shen R; Zhang R; Zhu D; Wang L; Lin S; Lv L; Huang K
BMC Cardiovasc Disord; 2023 Jul; 23(1):362. PubMed ID: 37464328
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure and risk of venous thromboembolism: a cohort analysis of 5.5 million UK adults and Mendelian randomization studies.
Nazarzadeh M; Bidel Z; Mohseni H; Canoy D; Pinho-Gomes AC; Hassaine A; Dehghan A; Tregouet DA; Smith NL; Rahimi K;
Cardiovasc Res; 2023 May; 119(3):835-842. PubMed ID: 36031541
[TBL] [Abstract][Full Text] [Related]
7. Genetic Analysis of Venous Thromboembolism in UK Biobank Identifies the ZFPM2 Locus and Implicates Obesity as a Causal Risk Factor.
Klarin D; Emdin CA; Natarajan P; Conrad MF; ; Kathiresan S
Circ Cardiovasc Genet; 2017 Apr; 10(2):. PubMed ID: 28373160
[TBL] [Abstract][Full Text] [Related]
8. Taller height as a risk factor for venous thromboembolism: a Mendelian randomization meta-analysis.
Roetker NS; Armasu SM; Pankow JS; Lutsey PL; Tang W; Rosenberg MA; Palmer TM; MacLehose RF; Heckbert SR; Cushman M; de Andrade M; Folsom AR
J Thromb Haemost; 2017 Jul; 15(7):1334-1343. PubMed ID: 28445597
[TBL] [Abstract][Full Text] [Related]
9. A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.
Hyppönen E; Mulugeta A; Zhou A; Santhanakrishnan VK
Lancet Digit Health; 2019 Jul; 1(3):e116-e126. PubMed ID: 33323262
[TBL] [Abstract][Full Text] [Related]
10. Mendelian Randomization Study Does Not Support a Bidirectional Link between Atherosclerosis and Venous Thromboembolism.
Hu M; Gong Z; Yang Y
J Atheroscler Thromb; 2023 Sep; 30(9):1265-1275. PubMed ID: 36529488
[TBL] [Abstract][Full Text] [Related]
11. Genetically predicted cortisol levels and risk of venous thromboembolism.
Allara E; Lee WH; Burgess S; ; Larsson SC
PLoS One; 2022; 17(8):e0272807. PubMed ID: 35984822
[TBL] [Abstract][Full Text] [Related]
12. No evidence for a genetic causal effect of breast cancer on venous thromboembolism: a mendelian randomization study.
Qin Q; Pan Y; Wang L
J Thromb Thrombolysis; 2024 Jan; 57(1):117-123. PubMed ID: 37615800
[TBL] [Abstract][Full Text] [Related]
13. The impact of glycated hemoglobin on risk of hypertension: a Mendelian randomization study using UK Biobank.
Au Yeung SL; Luo S; Schooling CM
J Hypertens; 2020 Jan; 38(1):38-44. PubMed ID: 31386636
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hyperthyroidism on Venous Thromboembolism: A Mendelian Randomization Study.
Han F; Zhang C; Xuan M; Xie Z; Zhang K; Li Y
J Immunol Res; 2022; 2022():2339678. PubMed ID: 36277472
[TBL] [Abstract][Full Text] [Related]
15. Association of genetically predicted testosterone with thromboembolism, heart failure, and myocardial infarction: mendelian randomisation study in UK Biobank.
Luo S; Au Yeung SL; Zhao JV; Burgess S; Schooling CM
BMJ; 2019 Mar; 364():l476. PubMed ID: 30842065
[TBL] [Abstract][Full Text] [Related]
16. Blood Cells and Venous Thromboembolism Risk: A Two-Sample Mendelian Randomization Study.
He J; Jiang Q; Yao Y; Shen Y; Li J; Yang J; Ma R; Zhang N; Liu C
Front Cardiovasc Med; 2022; 9():919640. PubMed ID: 35872889
[TBL] [Abstract][Full Text] [Related]
17. The Causality between Diabetes and Venous Thromboembolism: A Bidirectional Two-Sample Mendelian Randomization Study.
Hu S; Tan JS; Hu MJ; Guo TT; Chen L; Hua L; Cao J
Thromb Haemost; 2023 Sep; 123(9):913-919. PubMed ID: 36812941
[TBL] [Abstract][Full Text] [Related]
18. Statins and risk of venous thromboembolic diseases: A two-sample mendelian randomization study.
Ma XS; Sun J; Geng R; Zhao Y; Xu WZ; Liu YH; Jiang YN; Li YQ
Nutr Metab Cardiovasc Dis; 2023 May; 33(5):1087-1092. PubMed ID: 36958971
[TBL] [Abstract][Full Text] [Related]
19. A Mendelian randomization of γ' and total fibrinogen levels in relation to venous thromboembolism and ischemic stroke.
Maners J; Gill D; Pankratz N; Laffan MA; Wolberg AS; de Maat MPM; Ligthart S; Tang W; Ward-Caviness CK; Fornage M; Debette S; Dichgans M; McKnight B; Boerwinkle E; ; ; ; Smith NL; Morrison AC; Dehghan A; de Vries PS
Blood; 2020 Dec; 136(26):3062-3069. PubMed ID: 33367543
[TBL] [Abstract][Full Text] [Related]
20. Mendelian randomization analysis of 37 clinical factors and coronary artery disease in East Asian and European populations.
Wang K; Shi X; Zhu Z; Hao X; Chen L; Cheng S; Foo RSY; Wang C
Genome Med; 2022 Jun; 14(1):63. PubMed ID: 35698167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
